SFRP4 and cancer: Comparing samples from relapse-free patients with relapse patients demonstrated significantly higher levels of SFRP4 in the relapse patients (Fig. 2b, Supplementary Table 2) when including cancer samples (logFC = 1.13, p = 0.019), but not when including all samples (logFC = 0.87, p = 0.06).